APA (7th ed.) Citation

W, L., S, L., X, Y., W, L., & X, L. (2026). Impact of Emphysema on Therapeutic Efficacy and Immune-Related Pneumonitis Risk in NSCLC Patients Receiving ICIs: A Meta-Analysis of Improved Survival but Increased Toxicity. International journal of chronic obstructive pulmonary disease, 21, 569504. https://doi.org/10.2147/COPD.S569504

Chicago Style (17th ed.) Citation

W, Li, Liu S, Yu X, Lan W, and Liu X. "Impact of Emphysema on Therapeutic Efficacy and Immune-Related Pneumonitis Risk in NSCLC Patients Receiving ICIs: A Meta-Analysis of Improved Survival but Increased Toxicity." International Journal of Chronic Obstructive Pulmonary Disease 21 (2026): 569504. https://doi.org/10.2147/COPD.S569504.

MLA (9th ed.) Citation

W, Li, et al. "Impact of Emphysema on Therapeutic Efficacy and Immune-Related Pneumonitis Risk in NSCLC Patients Receiving ICIs: A Meta-Analysis of Improved Survival but Increased Toxicity." International Journal of Chronic Obstructive Pulmonary Disease, vol. 21, 2026, p. 569504, https://doi.org/10.2147/COPD.S569504.